Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-20 8:13 pm Purchase |
2024-08-20 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
Advent Life Sciences LLP | 124,972 3.980% |
61,665 (+97.41%) |
Filing History |
| 2022-02-11 6:04 pm Unchanged |
2021-12-31 | 13G | Acutus Medical, Inc. AFIB |
Advent Life Sciences LLP | 1,619,371 5.800% |
0 (Unchanged) |
Filing History |
| 2022-02-11 5:59 pm Purchase |
2021-12-31 | 13G | Aura Biosciences, Inc. AURA |
Advent Life Sciences LLP | 2,023,857 6.900% |
2,023,857 (New Position) |
Filing History |
| 2021-04-13 2:05 pm Purchase |
2021-04-01 | 13D | Eloxx Pharmaceuticals, Inc. ELOX |
Advent Life Sciences LLP | 63,307 6.300% |
63,307 (New Position) |
Filing History |
| 2021-02-10 3:46 pm Purchase |
2020-12-31 | 13G | Acutus Medical, Inc. AFIB |
Advent Life Sciences LLP | 1,619,371 5.800% |
1,619,371 (New Position) |
Filing History |
| 2021-02-10 3:40 pm Purchase |
2020-07-01 | 13D | Iterum Therapeutics plc ITRM |
Advent Life Sciences LLP | 192,672 3.500% |
134,046 (+228.64%) |
Filing History |